BENTSUR RON 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-28 5:22 pm Purchase |
2022-03-17 | 13D | Nuvectis Pharma, Inc. NVCT |
BENTSUR RON | 2,728,700 21.460% |
2,728,700 (New Position) |
Filing |